跳至主要内容
临床试验/NCT05003076
NCT05003076
已完成
早期 1 期

Drug Effects on EEG

University of Chicago1 个研究点 分布在 1 个国家目标入组 40 人2021年7月1日

概览

阶段
早期 1 期
干预措施
Methamphetamine
疾病 / 适应症
Healthy
发起方
University of Chicago
入组人数
40
试验地点
1
主要终点
Change in SUbjective Effects as Assessed by Score on "Feel Drug", "Feel High", "Like Drug", and "Want More" Sub-scales of Drug Effects Questionnaire (DEQ).
状态
已完成
最后更新
2年前

概览

简要总结

In this project, we will examine effects of MA on reward function using electroencephalograms (EEG), which will complement our ongoing study with MA and fMRI. We will determine how MA alters reward-related neural activity and how this is related to its subjective rewarding effects. The effects of MA on reward function will be examined using both reward-task-related activation and resting state activity. We will examine the effects of MA on ratings of drug liking and euphoria, as well as on EEG measures sensitivity to reward. Healthy young adults will undergo three EEG sessions with placebo and MA (10 and 20 mg), while performing the Monetary Incentive Delay task and the Stop Task, as a measure of inhibition. We will examine correlations between the neural responses and subjective responses to MA.

Our central hypotheses are 1) that MA will increase feelings of alertness and well-being, and 2) that MA will increase neural responses to anticipation and receipt of reward, and 3) that the effects of MA on mood will be correlated with its effects on neural responses to reward.

注册库
clinicaltrials.gov
开始日期
2021年7月1日
结束日期
2023年4月1日
最后更新
2年前
研究类型
Interventional
研究设计
Crossover
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • BMI between 19 and 26 Less than 4 alcohol or caffeinated beverages a day.

排除标准

  • High blood pressure
  • Any medical condition requiring regular medication Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis Individuals with a history of dependence on stimulant drugs Women who are pregnant or trying to become pregnant.

研究组 & 干预措施

Placebo Then Methamphetamine

Participants first receive placebo at their first session in the laboratory. Then will return to the laboratory 72 hours later and will receive 20 mg methamphetamine.

干预措施: Methamphetamine

Placebo Then Methamphetamine

Participants first receive placebo at their first session in the laboratory. Then will return to the laboratory 72 hours later and will receive 20 mg methamphetamine.

干预措施: Placebo

Methamphetamine Then Placebo

Participants first receive 20 mg methamphetamine at their first session in the laboratory Then will return to the laboratory 72 hours later and will receive placebo.

干预措施: Methamphetamine

Methamphetamine Then Placebo

Participants first receive 20 mg methamphetamine at their first session in the laboratory Then will return to the laboratory 72 hours later and will receive placebo.

干预措施: Placebo

结局指标

主要结局

Change in SUbjective Effects as Assessed by Score on "Feel Drug", "Feel High", "Like Drug", and "Want More" Sub-scales of Drug Effects Questionnaire (DEQ).

时间窗: Time Frame: Day 1(baseline), 3

Participants will complete The Drug Effects Questionnaire during the initial baseline session to determine their subjective stimulant profile. The Dug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: "Feel Drug", "Feel High", "Like Drug", and "Want More". All sub-scales are scored on a visual analogue scale (Scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome.

研究点 (1)

Loading locations...

相似试验